All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
The lym Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the lym Hub cannot guarantee the accuracy of translated content. The lym and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Lymphoma & CLL Hub is an independent medical education platform, sponsored by AbbVie, BeOne Medicines, Johnson & Johnson, Roche and sobi, and supported through educational grants from Bristol Myers Squibb, Incyte, Lilly, and Pfizer. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View lym content recommended for you
EHA 2018: Abstract submission deadline
The 23rd Congress of the European Hematology Association (EHA) is being held in Stockholm, Sweden at the Stockholmsmässan Congress Center on the 14–17 June 2018. Abstract submission is due to close in three days’ time on 1 March 2018, at 23:59 CET. Furthermore, the deadline for EHA attendance registration is 10 May 2018.
The EHA, on their website, state that: “the 23rd Congress of EHA will offer you a program covering every subspecialty in hematology, as well as network opportunities with experts from all over the globe. The educational and scientific program will highlight state-of-the-art clinical practice, the latest findings in hematology research and many more interesting sessions. The Congress also provides satellite programs, Updates-in-Hematology and an exhibition organized by pharmaceutical companies."
The Lymphoma Hub will be covering key highlights from EHA 2018 during the congress including oral sessions, late breaking abstracts, and educational sessions, with a focus on the latest lymphoma research that impacts clinical practice.
References
Your opinion matters
Which of the following would most increase your confidence in referring patients with R/R large B-cell lymphoma for CAR T-cell therapy?